Ophthalmology runs on throughput — clinic chairs, diagnostic slots and theatre lists. Drapto measures revenue by procedure and surgeon, tracks utilisation, and shows which referral sources and camps actually produce paying surgery.
Throughput businesses live or die on the slot you did not fill.
When margin per procedure is thin, the difference between a full theatre list and a nearly full one is most of the profit. That makes utilisation the number that decides the year.
Cataract, refractive, retina and diagnostic work have very different economics. Measuring them separately, with surgeon contribution ranked inside the department, shows where the hospital actually earns.
Screening camps and referring optometrists generate volume, but only some of it converts to surgery that gets paid for. Measuring sources on revenue rather than footfall reorders where outreach effort belongs.
Measured slot and theatre usage turns unused capacity into something you can schedule against.
Camps and referrers measured on revenue produced, not on people seen, changes where effort goes.
Ageing catches scheme and insurer payments before they slide into the low-recovery band.
Ranking within department rather than across the hospital keeps the conversation credible.
No. Clinical and imaging systems stay as they are. Drapto measures the revenue and operational side.
Yes. Camps and outreach are treated as acquisition sources measured on the revenue they eventually produce.
Yes. Collection rate and ageing are reported regardless of payer mix, so the picture stays comparable.
Yes. All three agents run on your own AI provider key and work from data already in your account. The Revenue Leakage Analyst calculates deterministically, so every figure it reports is verifiable against your own books.